Circassia Group Plc (F:82C) — Market Cap & Net Worth
Market Cap & Net Worth: Circassia Group Plc (82C)
Circassia Group Plc (F:82C) has a market capitalization of $307.93 Million (€263.39 Million) as of April 21, 2026. Listed on the F stock exchange, this Germany-based company holds position #16414 globally and #2341 in its home market, demonstrating a 1.61% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Circassia Group Plc's stock price €0.63 by its total outstanding shares 418074453 (418.07 Million).
Circassia Group Plc Market Cap History: 2015 to 2026
Circassia Group Plc's market capitalization history from 2015 to 2026. Data shows change from $1.94 Billion to $307.93 Million (-15.23% CAGR).
Circassia Group Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Circassia Group Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.33x
Circassia Group Plc's market cap is 7.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
50.97x
Circassia Group Plc's market cap is 50.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $516.29 Million | $23.10 Million | -$137.30 Million | 22.35x | N/A |
| 2017 | $502.26 Million | $46.30 Million | -$99.10 Million | 10.85x | N/A |
| 2018 | $273.32 Million | $48.30 Million | -$117.10 Million | 5.66x | N/A |
| 2019 | $94.38 Million | $62.40 Million | -$48.30 Million | 1.51x | N/A |
| 2020 | $127.33 Million | $23.90 Million | -$33.50 Million | 5.33x | N/A |
| 2021 | $216.82 Million | $27.90 Million | $3.60 Million | 7.77x | 60.23x |
| 2022 | $175.67 Million | $31.30 Million | $16.10 Million | 5.61x | 10.91x |
| 2023 | $337.99 Million | $36.80 Million | $10.70 Million | 9.18x | 31.59x |
| 2024 | $344.58 Million | $41.80 Million | $3.70 Million | 8.24x | 93.13x |
| 2025 | $356.80 Million | $48.70 Million | $7.00 Million | 7.33x | 50.97x |
Competitor Companies of 82C by Market Capitalization
Companies near Circassia Group Plc in the global market cap rankings as of April 21, 2026.
Key companies related to Circassia Group Plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $168.34 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #148 globally with a market cap of $131.38 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #185 globally with a market cap of $110.50 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #224 globally with a market cap of $95.25 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $168.34 Billion | $96.81 |
| #148 | Stryker Corporation | NYSE:SYK | $131.38 Billion | $343.32 |
| #185 | Medtronic PLC | NYSE:MDT | $110.50 Billion | $86.19 |
| #224 | Boston Scientific Corp | NYSE:BSX | $95.25 Billion | $64.23 |
Circassia Group Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Circassia Group Plc's market cap moved from $1.94 Billion to $ 307.93 Million, with a yearly change of -15.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €307.93 Million | -13.70% |
| 2025 | €356.80 Million | +3.55% |
| 2024 | €344.58 Million | +1.95% |
| 2023 | €337.99 Million | +92.40% |
| 2022 | €175.67 Million | -18.98% |
| 2021 | €216.82 Million | +70.29% |
| 2020 | €127.33 Million | +34.90% |
| 2019 | €94.38 Million | -65.47% |
| 2018 | €273.32 Million | -45.58% |
| 2017 | €502.26 Million | -2.72% |
| 2016 | €516.29 Million | -73.41% |
| 2015 | €1.94 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 20th, 2026 the market cap of Circassia Group Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $307.93 Million USD |
| MoneyControl | $307.93 Million USD |
| MarketWatch | $307.93 Million USD |
| marketcap.company | $307.93 Million USD |
| Reuters | $307.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Circassia Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more